نتایج جستجو برای: eluting stents treatment failure myocardial infarction

تعداد نتایج: 1845761  

Journal: :Journal of the American College of Cardiology 2007
Maurizio Menichelli Antonio Parma Edoardo Pucci Rosario Fiorilli Francesco De Felice Marco Nazzaro Alessia Giulivi Domenico Alborino Arianna Azzellino Roberto Violini

OBJECTIVES To confirm whether sirolimus-eluting stents (SES) safely reduce the incidence of restenosis in patients with ST-segment elevation acute myocardial infarction compared with bare-metal stents (BMS). BACKGROUND In the setting of primary angioplasty, stent restenosis occurs in up to 27% of patients. The introduction of drug-eluting stents has drastically reduced the incidence of resten...

Journal: :Journal of the American College of Cardiology 2021

Outcomes data for a durable-polymer everolimus-eluting stent (EES) at extended long-term follow-up in patients with ST-segment elevation myocardial infarction (STEMI) are unknown. The aim of this study was to assess the 10-year outcomes enrolled EXAMINATION (A Clinical Evaluation Everolimus Eluting Coronary Stents Treatment Patients With ST-Segment Elevation Myocardial Infarction) trial. EXAMIN...

2012
Hyeon-Cheol Gwon Kyung Woo Park Jin-Ho Choi Seung-Hyuk Choi Jung-Han Yoon Myung-Ho Jeong Woo-Young Chung Young-Jin Choi Seung-Ho Hur Dong-Woon Jeon

Background—The optimal duration of dual antiplatelet therapy (DAPT) after implantation of drug-eluting coronary stents remains undetermined. We aimed to test whether 6-month DAPT would be noninferior to 12-month DAPT after implantation of drug-eluting stents. Methods and Results—We randomly assigned 1443 patients undergoing implantation of drug-eluting stents to receive 6-or 12-month DAPT (in a...

Journal: :The American journal of medicine 2009
Henri Roukoz Anthony A Bavry Michael L Sarkees Girish R Mood Dharam J Kumbhani Mark G Rabbat Deepak L Bhatt

BACKGROUND Several observational reports have documented both increased and decreased cardiac mortality or Q-wave myocardial infarction with drug-eluting stents compared with bare-metal stents. METHODS We sought to evaluate the safety and efficacy of drug-eluting stents compared with bare-metal stents early after intervention (<1 year) and late (>1 year) among a broad population of patients, ...

2014
Stephan Windecker Stefan Stortecky Giulio G Stefanini Bruno R daCosta Anne Wilhelmina Rutjes Marcello Di Nisio Maria G Siletta Ausilia Maione Fernando Alfonso Peter M Clemmensen Jean-Philippe Collet Jochen Cremer Volkmar Falk Gerasimos Filippatos Christian Hamm Stuart Head Arie Pieter Kappetein Adnan Kastrati Juhani Knuuti Ulf Landmesser Günther Laufer Franz-Joseph Neumann Dimitri Richter Patrick Schauerte Miguel Sousa Uva David P Taggart Lucia Torracca Marco Valgimigli William Wijns Adam Witkowski Philippe Kolh Peter Juni

OBJECTIVE To investigate whether revascularisation improves prognosis compared with medical treatment among patients with stable coronary artery disease. DESIGN Bayesian network meta-analyses to combine direct within trial comparisons between treatments with indirect evidence from other trials while maintaining randomisation. ELIGIBILITY CRITERIA FOR SELECTING STUDIES A strategy of initial ...

Journal: :Circulation 2012
Hyeon-Cheol Gwon Joo-Yong Hahn Kyung Woo Park Young Bin Song In-Ho Chae Do-Sun Lim Kyoo-Rok Han Jin-Ho Choi Seung-Hyuk Choi Hyun-Jae Kang Bon-Kwon Koo Taehoon Ahn Jung-Han Yoon Myung-Ho Jeong Taek-Jong Hong Woo-Young Chung Young-Jin Choi Seung-Ho Hur Hyuck-Moon Kwon Dong-Woon Jeon Byung-Ok Kim Si-Hoon Park Nam-Ho Lee Hui-Kyung Jeon Yangsoo Jang Hyo-Soo Kim

BACKGROUND The optimal duration of dual antiplatelet therapy (DAPT) after implantation of drug-eluting coronary stents remains undetermined. We aimed to test whether 6-month DAPT would be noninferior to 12-month DAPT after implantation of drug-eluting stents. METHODS AND RESULTS We randomly assigned 1443 patients undergoing implantation of drug-eluting stents to receive 6- or 12-month DAPT (i...

Journal: :Lancet 2010
Elvin Kedhi Kaiyum Sheik Joesoef Eugene McFadden Jochem Wassing Carlos van Mieghem Dick Goedhart Pieter Cornelis Smits

BACKGROUND Everolimus-eluting and paclitaxel-eluting stents, compared with bare metal stents, reduced the risk of restenosis in clinical trials with strict inclusion and exclusion criteria. We compared the safety and efficacy of the second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice. METHODS We randomly assigned 1800 consecutive patients (aged 18-85 years...

2013
Sripal Bangalore Bora Toklu Nicholas Amoroso Mario Fusaro Sunil Kumar Edward L Hannan David P Faxon Frederick Feit

OBJECTIVE To compare the efficacy and safety of biodegradable polymer drug eluting stents with those of bare metal stents and durable polymer drug eluting stents. DESIGN Mixed treatment comparison meta-analysis of 258,544 patient years of follow-up from randomized trials. DATA SOURCES AND STUDY SELECTION PubMed, Embase, and Central were searched for randomized trials comparing any of the Fo...

Journal: :Circulation. Cardiovascular interventions 2015
Javaid Iqbal Patrick W Serruys Sigmund Silber Henning Kelbaek Gert Richardt Marie-Angele Morel Manuela Negoita Pawel E Buszman Stephan Windecker

BACKGROUND Newer-generation drug-eluting stents that release zotarolimus or everolimus have been shown to be superior to the first-generation drug-eluting stents. However, data comparing long-term safety and efficacy of zotarolimus- (ZES) and everolimus-eluting stents (EES) are limited. RESOLUTE all-comers (Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-Eluting Stent fo...

Journal: :Revista espanola de cardiologia 2014
José M de la Torre Hernández Fernando Alfonso Victoria Martin Yuste Angel Sánchez Recalde Manuel F Jimenez Navarro Armando Pérez de Prado Felipe Hernández Omar Abdul-Jawad Altisent Gerard Roura Tamara García Camarero Jaime Elizaga Ramón Calviño Jose Moreu Francisco Bosa Jesús Jimenez Mazuecos José R Ruiz-Arroyo Bruno Garcia Del Blanco José R Rumoso

INTRODUCTION AND OBJECTIVES We sought to compare the long-term clinical outcome of with ST-segment elevation myocardial infarction treated with paclitaxel-eluting stents or everolimus-eluting stents and the influence of thrombectomy on outcomes. METHODS The ESTROFA-IM is a multicenter retrospective registry collecting consecutive patients with infarction treated with these stents in 16 center...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید